2[1]Rostand SG. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int, 1999, 56:383- 392
3[2]Giangrande A, Castiglioni A, Solbiati L, et al. Chemical parathyroidectomy for recurrence of secondary hyperparathyroidisim. Am J Kidney Dis, 1994, 24:421 - 426
4[3]Solbiati L, Giangrande A, De Pra L, et al. Pereutaneous ethanol injection of parathyroid tumors under US guidance: treatment for secondary hyperparathyroidisim. Radiology, 1985,155:607 - 610
5[4]Kitaoka M, Fukagawa M, Ogata E, et al. Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients. Kidney Int, 1994, 46:1110 - 1117
6[5]Fukagawa M, Tominaga Y, Kitaoka M, et al. Medical and surgical aspects of parathyroidectomy. Kidney Int, 1999, 56 ( suppl. 73): s65- s69
7[6]Fukagawa M, Kitaoka M, Yi H, et al. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the longterm prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron, 1994, 68: 221 - 228
8[8]Fukagawa M, Kitaoka M, Tominaga Y, et al. Selective percutanenous ethanol injection therapy (PEIT) of the parathyroid in chronic dialysis patients-the Japanese strategy. Nephrology Dial Transplant, 1999, 14:2574 - 2577
9[9]Kakuta T, Fukagawa M, Fujisaki T, et al. Prognosis of parathyroid function after successful PEIT guided by color Doppler flow mapping in chronic dialysis patients. Am J Kidney Dis, 1999, 33:1091 - 1099
